Thrombotic events with recombinant activated factor VII (rFVIIa) in approved indications are rare and associated with older age, cardiovascular disease, and concomitant use of acti...

por Rajpurkar, Madhvi, Croteau, Stacy E, Boggio, Lisa, Cooper, David L
Publicado 2019

High adherence to prophylaxis regimens in haemophilia B patients receiving rIX‐FP: Evidence from clinical trials and real‐world practice

por Mancuso, Maria Elisa, Oldenburg, Johannes, Boggio, Lisa, Kenet, Gili, Chan, Anthony, Altisent, Carmen, Seifert, Wilfried, Santagostino, Elena
Publicado 2020

A phase 1b/2 clinical study of marstacimab, targeting human tissue factor pathway inhibitor, in haemophilia

por Mahlangu, Johnny N., Lamas, Jose Luis, Morales, Juan Cristobal, Malan, Daniel R., Šalek, Silva Zupančić, Wang, Michael, Boggio, Lisa N., Hegemann, Inga, Mital, Andrzej, Cardinal, Matthew, Zhu, Tong, Sun, Pengling, Arkin, Steven
Publicado 2022